eInfochips launches Andromeda Reference Platform for medical imaging and telemedicine designers

The video processing system includes the system hardware and software that design teams need for fast time-to-application development

eInfochips, a leading product design company, today launched the Andromeda Reference Platform for medical imaging and telemedicine designers. The Andromeda video processing system is an app-ready development platform for medical imaging systems including endoscopy, angiography, mammography, arthroscopy and ultrasound. For telemedicine engineers, Andromeda also is a wireless-ready platform for applications that connect doctors, patients and families together on a network. For both medical imaging and telemedicine design teams, Andromeda accelerates prototype development while reducing costs.

According to Frank Berry, founder and senior analyst at IT Brand Pulse, "Medical imaging companies are focused on out-innovating each other. Reference platforms like Andromeda allow design teams to maintain that focus, and to get innovative products to market faster."

Parag Mehta, Chief Marketing and Business Development Officer at eInfochips, added: "Andromeda is designed to streamline manufacturing complexity as well. The same System-on-Module used in the development platform is designed for high-volume production."

The Andromeda Reference Platform

Reference Platforms from eInfochips include the system hardware and software design teams need for fast time-to-application development. The Andromeda Reference Platform is a wireless-ready video processing system, loaded with a Linux operating system, sample applications and documentation. The video processing system includes a carrier card, a video I/O module, a touch-screen display and an ultra-small form-factor system-on-module. The system-on-module is available with two versions of ARM Cortex A8-based Texas Instruments Digital Signal Processors: 1) the TMS320DM8148 with SGX530 Graphics Acceleration, and 2) the TMS320DM8168 with HD Video Acceleration.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New brain targets for GLP1-based obesity drugs may reduce weight without nausea